Dermatology · Fairborn, OH
Dermatology and skin studies in Fairborn, OH
5 recruiting studies have a site in Fairborn.
5 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
AbbVie
- Location
- Fairborn, OH + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- Fairborn, OH + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Takeda
- Location
- Fairborn, OH + 10 other US sites
- Eligibility basics
- Ages 4–17
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
UCB Biopharma SRL
- Location
- Fairborn, OH + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 2
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
Wright State University
- Location
- Fairborn, OH
- Eligibility basics
- Ages 18+
Who these studies look for
Most require an active, diagnosed skin condition of a certain severity and a pause on some current treatments before starting.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.